• SENSEX 82,530.74
    1,200.18 (+1.48%)
  • BANKNIFTY 55,355.60
    554.30 (+1.01%)
  • Cochin Shipyard
    1,831.00 2,977.10(%)
  • One 97
    863.90 1,063.00(%)
  • Mazagon Dock
    3,217.65 3,229.00(%)
  • Garden Reach Sh.
    2,340.00 2,834.60(%)
  • Tata Motors
    729.95 1,179.05(%)
  • Hind.Aeronautics
    4,883.00 5,675.00(%)
  • OneSource Speci.
    1,567.95 1,163.05(%)
  • Bharat Electron
    351.00 351.00(%)
  • Suzlon Energy
    61.77 86.04(%)
  • St Bk of India
    809.50 912.10(%)
  • Yes Bank
    21.70 27.41(%)
  • Reliance Industr
    1,461.00 1,608.95(%)
  • Vodafone Idea
    7.27 19.15(%)
  • Bharti Airtel
    1,869.65 1,916.90(%)
  • Tata Power Co.
    404.55 494.85(%)
  • Swiggy
    318.00 617.00(%)
  • Infosys
    1,618.85 2,006.80(%)
  • Dixon Technolog.
    16,520.00 19,149.80(%)
  • Jio Financial
    274.40 376.00(%)
  • ITC
    435.40 500.01(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
92.03 1 (0.67%)
  • As on 16 May 2025 (EOD)

  • Today’s Low

    90.05

  • Today’s High

    93.80

  • Open

    91.83

  • Perv Close

    91.42

  • 52W Low

    79.49

  • 52W High

    128.90

Key Indicators

  • P/E(TTM)

    31.41

  • Mar.Cap (₹Cr.)

    448.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    48.10

  • Debt-Equity Ratio

    0.67

  • AGM Date

    15-May-2025

  • EPS

    2.92

  • P/E Ratio

    31.41

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    448.42

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    48.73

  • BV (₹)

    48.10

  • Sales( ₹ in Cr.)

    365.47

  • NP (in Cr.)

    16.77

  • NP Var(%)

    -33.0

  • Div%

    0.0

  • CPS (₹)

    6.50

  • EPS (₹)

    3.40

  • Traded Value (₹ in Lakhs)

    446.86

  • 52 Week High

    128.90

  • 52 Week Low

    79.49

  • Price BSE

    92.0

  • Price NSE

    92.00

  • Market Capital( in Cr.)

    446.86

  • P/C Ratio

    14.20

  • P/E Ratio

    26.70

  • Price Vs.BV

    3.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 365.47 396.53 329.49 303.63 274.32 331.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 365.47 396.53 329.49 303.63 274.32 331.72
Other Income 4.69 6.43 4.51 2.45 4.66 2.05
Stock Adjustments 14.05 -16.46 9.67 1.11 6.40 0.12
Total Income 384.21 386.50 343.67 307.19 285.38 333.89
EXPENDITURE :            
Raw Materials 185.49 182.37 170.02 159.74 149.54 159.63
Power and Fuel Cost 13.47 11.09 9.14 7.04 7.47 7.19
Employee Cost 50.81 46.47 38.63 34.48 34.58 48.14
Other Manufacturing Expenses 31.97 27.30 23.76 19.02 22.37 6.66
Selling and Administration Expenses 51.66 55.69 54.44 43.70 40.96 63.26
Miscellaneous Expenses 6.03 5.95 5.24 9.12 6.01 4.54
Employee Benefit Expenses 50.81 46.47 38.63 34.48 34.58 48.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 339.42 328.87 301.23 273.11 260.94 289.42
Operating Profit 44.79 57.63 42.44 34.08 24.43 44.47
Interest 6.92 5.58 8.31 10.89 12.65 10.59
Gross Profit 37.87 52.05 34.13 23.19 11.78 33.88
Depreciation 14.83 16.13 14.84 14.61 13.27 11.14
Profit Before Tax 23.04 35.92 19.29 8.58 -1.49 22.74
Current Tax 0.83 6.28 3.40 0.02 -0.12 4.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 5.45 4.63 2.88 2.95 -3.10 1.82
Reported Net Profit 16.76 25.01 13.01 5.62 1.74 16.01
Extraordinary Items -0.01 0.00 0.00 -3.39 -0.01 -0.29
Adjusted Net Profit 16.77 25.01 13.01 9.01 1.75 16.30
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.49 0.00
P & L Balance brought forward 136.36 111.81 98.76 93.52 92.54 77.92
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.38 0.46 -0.05 0.39 1.24 1.39
P & L Balance carried down 152.73 136.36 111.81 98.76 93.52 92.54
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 5.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.50
Earnings Per Share-Unit Curr 3.44 5.13 8.01 3.46 1.08 9.93
Earnings Per Share(Adj)-Unit Curr 3.44 5.13 2.67 1.15 0.36 3.31
Book Value 47.60 39.85 104.73 96.69 93.79 93.81
Book Value(Adj)-Unit Curr 47.60 39.85 34.91 32.23 31.26 31.27

Shareholding Pattern

  • Promoter Group

    33.26%

  • Public Share Holding

    66.74%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,207,980 33.26 16,207,980 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,207,980 33.26 16,207,980 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 5,171 0.01 5,171 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 115,780 0.24 115,780 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 120,951 0.25 120,951 4
2] Non Institution
Bodies Corporate 3,675,739 7.54 3,627,739 114
Clearing Members 0 0.00 0 0
Directors of their Relatives 722,537 1.48 722,337 10
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,174,953 4.46 640,445 262
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 452,227 0.93 451,627 368
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,233,518 29.21 14,188,398 57
Individuals holding nominal share capital up to Rs. 1 lakh 9,047,672 18.57 8,123,272 16,615
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,748,960 3.59 1,748,960 1
Sub Total 32,396,883 66.49 29,844,055 17,438
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,725,814 100.00 46,172,986 17,448

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015

  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar S Daud

  • Managing Director

    Anwar S Daud

  • Company Secretary

    Piyush Nikhadi

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 91.71 370.16 365.47 31.41 9.99
Abbott India 30,371.20 6,097.18 5,848.91 48.36 44.71
Astrazeneca Phar 7,947.60 1,330.33 1,295.53 204.89 33.26
P & G Health Ltd 5,247.85 1,166.89 1,151.26 36.82 39.76
Glaxosmi. Pharma 2,878.70 3,530.73 3,407.25 53.06 44.44
Cipla 1,502.25 17,645.00 16,574.34 23.52 20.10
Amrutanjan Healt 717.35 437.58 421.23 42.05 20.84
Guj. Themis Bio. 325.45 174.19 169.82 67.38 44.82
Fermenta Biotec. 288.75 315.24 307.09 27.37 4.10
Bliss GVS Pharma 120.45 638.96 605.46 18.39 11.19
Ambalal Sarabhai 38.18 11.70 3.81 16.32 1.92